{"id": "1384409536975589376", "creation": 1618903929.0, "user_id": "1195310926976765952", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 2, "reply_count": 0, "like_count": 1, "quote_count": 0}}, "text": "New in @TheLancetInfDis&gt; Safety and immunogenicity of #SARSCoV2 recombinant protein #vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1\u20132, dose-ranging study https://t.co/pSKAIqe8B5 #COVID19", "first_save": 1634559108.199414, "hashtags": ["#SARSCOV2", "#VACCINE", "#COVID19"]}